Arcus Biosciences, Inc. · NYSE:RCUS
Point72 Asset Management, L.P. reported a 5.50% stake in Arcus Biosciences, Inc. (Schedule 13G)
Event May 12, 2025 · Filed May 13, 2025
Point72 Asset Management, L.P. reported a 5.50% stake in Arcus Biosciences, Inc., 5,831,099 shares, as a passive investor on May 12, 2025. Filed May 13, 2025 (Schedule 13G).
- Stake
- 5.50%
- Shares
- 5,831,099
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.50% | 5,831,099 |
| Point72 Capital Advisors, Inc. | 5.50% | 5,831,099 |
| Steven A. Cohen | 5.50% | 5,831,099 |
Source
Related
- Arcus Biosciences, Inc.
- Point72 Asset Management, L.P.
- Arcus Biosciences, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 14, 2025
- Form 4 · Azoy Alexander · Aug 24, 2026
- Schedule 13D/A · Gilead Sciences, Inc. · Aug 7, 2026
- Form 4 · Jaen Juan C. · Jul 13, 2026
- Form 4 · Jaen Juan C. · Jun 24, 2026
- Form 4 · Lambert Nicole · Jun 12, 2026